Article Versions Notes

Santos I, Ramos C, Mendes C, Sequeira CO, Tomé CS, Fernandes DGH, Mota P, Pires RF, Urso D, Hipólito A, et al. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation. Nutrients. 2019; 11(10):2523. https://doi.org/10.3390/nu11102523

Santos, Inês, Cristiano Ramos, Cindy Mendes, Catarina O. Sequeira, Catarina S. Tomé, Dalila G.H. Fernandes, Pedro Mota, Rita F. Pires, Donato Urso, Ana Hipólito, and et al. 2019. "Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation" Nutrients 11, no. 10: 2523. https://doi.org/10.3390/nu11102523

Santos, I., Ramos, C., Mendes, C., Sequeira, C. O., Tomé, C. S., Fernandes, D. G. H., Mota, P., Pires, R. F., Urso, D., Hipólito, A., Antunes, A. M. M., Vicente, J. B., Pereira, S. A., Bonifácio, V. D. B., Nunes, S. C., & Serpa, J. (2019). Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation. Nutrients, 11(10), 2523. https://doi.org/10.3390/nu11102523